CanSino Biologics Inc. (688185) has confirmed the cancellation of 406,098 treasury shares repurchased from 7 February 2022 to 1 December 2022. According to the disclosure, this action took effect on 27 November 2025.
The opening balance on 31 October 2025 was 114,372,901 issued shares (excluding treasury shares) and 406,098 treasury shares. After the cancellation, issued shares remain at 114,372,901, while treasury shares now stand at zero. The document indicates no outstanding shares awaiting cancellation and no recordable on-market sale of treasury shares during the relevant period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments